Texas kicks in for vegan vaccine funding

Oddly in line with last week's federal announcement setting in motion a medical countermeasures makeover in the U.S., the state of Texas is awarding $4 million for a production center that aims to churn out more than a billion doses annually of tobacco-plant-based influenza vaccine. The award comes from a Texas commission formed to help communities hurt by military base closures.

The money will fund facility construction at Bryan-College Station, on the Texas A&M Health Science Center campus, which is in the vicinity of a military base closed 50 years ago, says the Texas Tribune. The state has many more recent base closures that have affected their communities.

But Project GreenVax is spearheaded by the Texas Plant-Expressed Vaccine Consortium, which is based at the 145,000-square-foot National Center for Therapeutics Manufacturing located at Texas A&M. GreenVax occupies a 13,500-square-meter prefab unit comprising modules for tobacco-growing and research.

-see the article

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)